Lightnews — Scholar-powered news

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 17h

📑 Drug-resistant infections have reached a tipping point. Without urgent action, #AMR deaths could rise by 70% by 2050.

We need innovation and access to the right antibiotics. 🌍

🔗Read Dr Manica Balasegaram’s @theguardian.com piece: www.theguardian.com/global-devel...

‘As new infections outpace new drugs, are we sleepwalking into a global health disaster?’ | Dr Manica Balasegaram

Much of the political momentum around the antimicrobial resistance crisis has dissipated, but a new report shows the danger to our health has not

www.theguardian.com

1

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 22h

🌍 At #WHS2025, GARDP’s Peter Beyer highlighted the impact of tech transfers in a #GSK session.

"Technology transfer isn’t just about moving a production line; it’s about sharing know-how, building local capabilities, and ensuring that life-saving antibiotics can be sustainably manufactured."

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 1d

🚨 @who.int reports a sharp global rise in antibiotic-resistant infections in hospitals.

"Until now, the #AMR narrative has focused rightfully on the overuse of antibiotics, but this isn’t enough." - Manica Balasegaram

@iansample.bsky.social for @theguardian.com
www.theguardian.com/world/2025/o...

Sharp global rise in antibiotic-resistant infections in hospitals, WHO finds

Experts describe findings as deeply concerning and predict 70% increase in related deaths by 2050

www.theguardian.com

4

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 1d

Winners will receive:

- A €5,000 award to support their work
- A storytelling bootcamp with global experts
- An all-expenses-paid trip to Italy for the award ceremony
- The opportunity to share their work and build collaborations at Penta’s biennial scientific event.

2

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 1d

The BFA spotlights health champions working at the grassroots and amplify their impact.

Nominations for the 2025-26 edition are open until 31 October 2025, 17:00 CET.

1 2

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 1d

Nominations are now open for the second edition of the Penta Brighter Future Award (BFA), a biennial international award that celebrates inspiring contributions to maternal and child health worldwide.

👉 Submit your nomination: penta-id.org/bfa

1 1 2

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 2d

Your input is highly appreciated, and we are looking forward to developing new exciting and enlightening content soon – watch this space!

🔗https://revive.gardp.org/

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 2d

We recently had the pleasure to discuss the progress of the #REVIVE programme and potential new activities in our second annual advisory meeting.

A big Thank You to our 2026 REVIVE programme Advisory Group members.

1 1 1

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 2d

💡 He also praised Japan’ innovation:
"The government’s initiative on clinical decision support system (CDSS) to further optimize utilization of antimicrobials is a strong example of next-gen leadership."

1

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 2d

When asked what GARDP expects from Japan in the fight against #AMR at the Nikkei-FT Infectious Disease Conference session, Rahul Dwivedi of #GARDP said:
“Japan’s leadership is vital—especially in enabling access. With
Shionogi and CHAI, we’re working to expand antibiotic access in 135 countries.”

1

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 4d

GARDP joined 40+ global scientists in Geneva to help shape Drug Design for Global Health (dd4gh) — an AI and machine-learning platform being co-created by MMV and deepmirror.

It aims to accelerate identification of promising drug compounds for global health research.

🔗 bit.ly/4h0I1pe

Co-creating an innovative AI platform to advance global health research | Medicines for Malaria Venture

Researchers from around the world collaborate with MMV and deepmirror to adapt machine-learning platform to accelerate drug discovery.

www.mmv.org

2

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 5d

@who.int’s latest report on bacterial diagnostics highlights persistent gaps in rapid, affordable tools — especially where the need is greatest.

GARDP’s Teri Roberts contributed as part of the WHO expert group.

🔗 Read more: www.who.int/publications...

Landscape analysis of commercially available and pipeline in vitro diagnostics for bacterial priority pathogens

This report maps the available and pipeline diagnostics to detect and identify WHO bacterial priority pathogens and to perform phenotypic antimicrobial susceptibility testing (AST) or genotypic testin...

www.who.int

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 5d

@who.int’s new report shows the antibacterial R&D pipeline is shrinking — just 90 candidates remain in development, with limited innovation against critical pathogens.

Strengthening both discovery and access is key to tackling AMR.

🔗Read the report: www.who.int/publications...

Analysis of antibacterial agents in clinical and preclinical development: overview and analysis 2025

The World Health Organization’s (WHO) “2025 Antibacterial agents in clinical and preclinical development: an overview and analysis” report provides a comprehensive evaluation of the global antibacteri...

www.who.int

2 2

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 6d

📝 Call for abstracts is open for #ACC2026!

Researchers are invited to share their work on #AMR for short talks or poster presentations.

💡 Themes: child & maternal health, stewardship & access, clinical research, AI in health & more.

⏳ Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters

2 1

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 7d

📍 Live from Osaka!

At the Nikkei–FT Infectious Disease Conference 2025, GARDP's Rahul Dwivedi joined global health leaders to discuss the urgent need to strengthen R&D and funding for infectious diseases.

🗞️🔗Read the Nikkei article published last night covering it

nikkei.com/article/DGXZ...

日本経済新聞 - ニュース・速報最新情報

日本経済新聞の電子版。日経や日経ＢＰの提供する経済、企業、国際、政治、マーケット、情報・通信、社会など各分野のニュース。ビジネス、マネー、IT、スポーツ、住宅、キャリアなどの専門情報も満載。

nikkei.com

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 7d

Finally, #BioJapan2025 starts tomorrow!

📍October 8–10 | Pacifico Yokohama

This year, we’re exhibiting again at the Swiss Pavilion (C-60)✨

💡GARDP is tackling drug-resistant bacterial infections. Come visit us to explore new partnerships and collaboration opportunities!

#SwissInnovation #AMR

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 7d

🤝 Our team met with Shionogi’s CEO Dr Teshirogi, and Vice Chairperson Ms Sawada, to reaffirm our shared commitment to addressing #AMR.

Since 2022, Shionogi Japan has been collaborating with GARDP to ensure access to its innovative antibiotic in 135 countries worldwide. 💊

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 8d

The @who.int’s updated Global Action Plan on #AMR, due in 2026, represents a pivotal opportunity to reshape the response to AMR.

GARDP calls for focus on four key areas:

1️⃣ Access to antibiotics
2️⃣ Children & newborns
3️⃣ Public-private partnerships
4️⃣ Financing the AMR response

🔗 bit.ly/48NxgV8

GARDP Statement on the Global Action Plan on AMR update | GARDP

In May 2026, the World Health Assembly will consider adoption of an updated World Health Organization (WHO) Global Action Plan on AMR (GAP). The initial action

bit.ly

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 10d

💬 Dr Jennifer Cohn shared this insight during a session at Keio University in Japan with over 60 participants, including AMR experts, healthcare professionals and students on global AMR countermeasures.

1

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 10d

"Ensuring access to antibiotics in LMICs doesn’t mean compromising stewardship. It means investing in systems – training, diagnostics, guidelines – that enable appropriate use from day one."

– Jennifer Cohn, GARDP

2 1

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 10d

This week, GARDP joined the PDP Funders Group in Thailand.

Highlights from the visit 👇

🏥 Siriraj Hospital, Mahidol University – Study on #gonorrhoea & chlamydia in pregnant women.

🧬 Bangrak STIs Center – Insights from Thailand’s first gonorrhoea trial in 40 years (zoliflodacin).

1 1

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 10d

The GARDP team met with Member of the House of Representatives Hirofumi Niki to thank the Japanese Government for its support.

💬 We discussed #AMR, sustainable antibiotic supply and Japan’s role in global health. Dr Niki stressed the importance of public engagement and awareness. 📢

1 1

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 10d

During our Tokyo visit, we met Ms Akiko Honda, Member of the House of Councillors, to discuss Japan’s role in global health🌍

💬 She underlined the importance of public support to strengthen cooperation, especially on #AMR. We shared how GARDP’s work delivers value to the Japanese public.

Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 11d

🎤 GARDP team members Alan Hennessy, Renata da Costa, and Dianna Taylor presented at #GAMRIC2025.

Topics:
1️⃣ Discovery & Exploratory Research
2️⃣ Molecular characterization of CRE & CRPA in hospitalized patients from India

Excited to share insights on antibiotic R&D and access!

1 4

Reposted by Global Antibiotic R&D Partnership (GARDP)

LifeArc @lifearc.bsky.social · 11d

That's a wrap on #GAMRIC2025! See today's highlights over on LinkedIn - t.ly/nr1sV

Thanks to all who attended and we look forward to seeing you again next year for #GAMRIC2026.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

3 4